• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围绕不同化学实体的详尽比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA):一项基于配体的研究,探索5-羟色胺(5-HT)配体的亲和力和选择性特征。

Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT ligands.

作者信息

Guariento Sara, Franchini Silvia, Tonelli Michele, Fossa Paola, Sorbi Claudia, Cichero Elena, Brasili Livio

机构信息

a Department of Pharmacy , University of Genoa , Genoa , Italy.

b Department of Life Sciences , University of Modena and Reggio Emilia , Modena , Italy.

出版信息

J Enzyme Inhib Med Chem. 2017 Dec;32(1):214-230. doi: 10.1080/14756366.2016.1247057.

DOI:10.1080/14756366.2016.1247057
PMID:28114832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6009877/
Abstract

The 5-hydroxytryptamine (5-HT) receptors represent an attractive target in drug discovery. In particular, 5-HT agonists and partial agonists are deeply investigated for their potential role in the treatment of anxiety, depression, ischaemic brain disorder and more recently, of pain. On the other hand, 5-HT antagonists have been revealed promising compounds in cognition disorders and, lately, in cancer. Thus, the discovery of 5HT ligands is nowadays an appealing research activity in medicinal chemistry. In this work, Comparative Molecular Fields Analysis (CoMFA) and Comparative Molecular Similarity Index Analysis (CoMSIA) were applied on an in-house library of 5-HT ligands bearing different chemical scaffolds in order to elucidate their affinity and selectivity for the target Following this procedure, a number of structural modifications have been drawn for the development of much more effective 5-HTR ligands. [Formula: see text].

摘要

5-羟色胺(5-HT)受体是药物研发中一个具有吸引力的靶点。特别是,5-HT激动剂和部分激动剂因其在治疗焦虑、抑郁、缺血性脑疾病以及最近在疼痛治疗中的潜在作用而受到深入研究。另一方面,5-HT拮抗剂在认知障碍以及最近在癌症治疗中已被证明是有前景的化合物。因此,如今发现5-HT配体是药物化学中一项有吸引力的研究活动。在这项工作中,比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)被应用于一个内部的5-HT配体库,这些配体具有不同的化学支架,以阐明它们对靶点的亲和力和选择性。按照这个程序,已经为开发更有效的5-HTR配体进行了一些结构修饰。[公式:见正文]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/e3b05b0e482c/IENZ_A_1247057_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/22dae0beaefe/IENZ_A_1247057_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/23cdc3523dc0/IENZ_A_1247057_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c0f716a0bdfe/IENZ_A_1247057_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c6e084de980a/IENZ_A_1247057_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/50ec47d60e8e/IENZ_A_1247057_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/59af033cb12c/IENZ_A_1247057_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c3bade2cec9d/IENZ_A_1247057_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/d976a2053ca6/IENZ_A_1247057_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/8f53fc366a0f/IENZ_A_1247057_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/e3b05b0e482c/IENZ_A_1247057_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/22dae0beaefe/IENZ_A_1247057_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/23cdc3523dc0/IENZ_A_1247057_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c0f716a0bdfe/IENZ_A_1247057_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c6e084de980a/IENZ_A_1247057_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/50ec47d60e8e/IENZ_A_1247057_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/59af033cb12c/IENZ_A_1247057_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/c3bade2cec9d/IENZ_A_1247057_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/d976a2053ca6/IENZ_A_1247057_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/8f53fc366a0f/IENZ_A_1247057_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bc/6009877/e3b05b0e482c/IENZ_A_1247057_F0010_C.jpg

相似文献

1
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT ligands.围绕不同化学实体的详尽比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA):一项基于配体的研究,探索5-羟色胺(5-HT)配体的亲和力和选择性特征。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):214-230. doi: 10.1080/14756366.2016.1247057.
2
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT Receptor.多功能的2-取代咪唑啉核作为靶向血清素5-HT受体的配体结构基序
ChemMedChem. 2016 Oct 19;11(20):2287-2298. doi: 10.1002/cmdc.201600383. Epub 2016 Sep 30.
3
5-HT and 5-HT receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives.一系列8-乙酰基-7-羟基-4-甲基香豆素衍生物的5-羟色胺和5-羟色胺受体亲和力、对接研究及药理学评价
Bioorg Med Chem. 2018 Jan 15;26(2):527-535. doi: 10.1016/j.bmc.2017.12.016. Epub 2017 Dec 9.
4
5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.5-HT1A 受体药效团筛选用于筛选 α1-肾上腺素能受体拮抗剂的非靶标活性。
J Comput Aided Mol Des. 2013 Apr;27(4):305-19. doi: 10.1007/s10822-013-9647-5. Epub 2013 Apr 27.
5
Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.芳基哌嗪链与 5-HT1a、5-HT2a 和 5-HT7 受体的结合模式。
Mini Rev Med Chem. 2013 Aug;13(10):1516-39. doi: 10.2174/1389557511313100012.
6
Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.对 WAY-100635 进行适度的化学修饰可以提高其对 5-HT1A 受体与 D4 受体的选择性。
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4550-4. doi: 10.1016/j.bmcl.2012.05.119. Epub 2012 Jun 7.
7
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT and 5-HT G protein-coupled receptor affinity, 3D-QSAR and molecular modeling.新型 5-取代-2-氨基四氢萘类化合物的合成:5-HT 和 5-HT G 蛋白偶联受体亲和力、3D-QSAR 和分子模拟。
Bioorg Med Chem. 2020 Feb 1;28(3):115262. doi: 10.1016/j.bmc.2019.115262. Epub 2019 Dec 12.
8
SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.使用CORAL构建的基于SMILES的芳基哌嗪类作为高亲和力5-HT(1A)受体配体的QSAR模型。
Eur J Pharm Sci. 2013 Feb 14;48(3):532-41. doi: 10.1016/j.ejps.2012.12.021. Epub 2012 Dec 31.
9
Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.基于药效团的高亲和力 5-HT1A 受体配体的 3D QSAR 研究。
Eur J Med Chem. 2010 Apr;45(4):1508-14. doi: 10.1016/j.ejmech.2009.12.059. Epub 2010 Jan 13.
10
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.含内酰胺或酰亚胺部分的 1,3-二恶烷类配体:在α1-肾上腺素受体亚型和 5-HT1A 受体上的结构-亲和力/活性关系。
Eur J Med Chem. 2010 Sep;45(9):3740-51. doi: 10.1016/j.ejmech.2010.05.023. Epub 2010 May 15.

引用本文的文献

1
SerotoninAI: Serotonergic System Focused, Artificial Intelligence-Based Application for Drug Discovery.基于人工智能的血清素能系统聚焦药物研发应用
J Chem Inf Model. 2024 Apr 8;64(7):2150-2157. doi: 10.1021/acs.jcim.3c01517. Epub 2024 Jan 30.
2
Identification of a Potent and Selective 5-HT Receptor Agonist with and Antinociceptive Activity.一种具有抗伤害感受活性的强效且选择性5-羟色胺受体激动剂的鉴定。
ACS Chem Neurosci. 2020 Dec 16;11(24):4111-4127. doi: 10.1021/acschemneuro.0c00289. Epub 2020 Dec 2.
3
Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques.

本文引用的文献

1
New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.磷酸二酯酶4B(PDE4B)抑制剂选择性的新见解:比较分子场分析(CoMFA)和分子对接研究
Mol Divers. 2016 Feb;20(1):77-92. doi: 10.1007/s11030-015-9631-1. Epub 2015 Aug 20.
2
Discovery of potent and selective urea-based ROCK inhibitors: Exploring the inhibitor's potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations.强效且选择性的基于尿素的ROCK抑制剂的发现:通过三维定量构效关系、分子对接和分子动力学模拟探索抑制剂的效力及ROCK2/PKA选择性
Bioorg Med Chem. 2015 May 15;23(10):2505-17. doi: 10.1016/j.bmc.2015.03.047. Epub 2015 Mar 25.
3
基于结构的药物设计技术对 EGFR 和 HER-2 抑制剂双重活性的研究。
Int J Mol Sci. 2018 Nov 23;19(12):3728. doi: 10.3390/ijms19123728.
4
Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies.通过基于分子动力学的受体依赖的 4D-QSAR 研究探讨二肽基肽酶-IV 抑制剂的结构见解。
Mol Divers. 2018 Aug;22(3):575-583. doi: 10.1007/s11030-018-9815-6. Epub 2018 Mar 13.
Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile.
具有多样化5-HT₁A受体功能特征的7-苯基哌嗪基烷基-1,3-二甲基嘌呤-2,6-二酮衍生物的抗抑郁和抗焦虑样活性
Bioorg Med Chem. 2015 Jan 1;23(1):212-21. doi: 10.1016/j.bmc.2014.11.008. Epub 2014 Nov 11.
4
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α<alpha>1 and 5-HT1A receptors.1,4-二恶烷螺[4.5]癸烷类配体在 α<alpha>1 和 5-HT1A 受体上的结构亲和力/活性关系。
Eur J Med Chem. 2014 Nov 24;87:248-66. doi: 10.1016/j.ejmech.2014.09.070. Epub 2014 Sep 27.
5
3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors.基于3D-QSAR/CoMFA的大麻素CB1和CB2受体中氨基烷基吲哚的结构-亲和力/选择性关系
Molecules. 2014 Mar 5;19(3):2842-61. doi: 10.3390/molecules19032842.
6
5-HT(1A) receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer.5-羟色胺(1A)受体:一个从中枢神经系统到癌症的新药发现的老靶点,也是一个新的有吸引力的工具。
J Med Chem. 2014 Jun 12;57(11):4407-26. doi: 10.1021/jm400533t. Epub 2013 Dec 10.
7
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.比较分子场分析(CoMFA)。1. 形状对类固醇与载体蛋白结合的影响。
J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005.
8
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.四氢呋喃-环戊酮和环戊醇基配体的合成、生物评价及在肾上腺素能α₁-和血清素 5-HT1A 受体上的对接研究。
J Med Chem. 2012 Jan 12;55(1):23-36. doi: 10.1021/jm200421e. Epub 2011 Dec 22.
9
Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiesterase inhibitors.基于对接的 CoMFA 和 CoMSIA 分析四氢-β-咔啉衍生物作为 5 型磷酸二酯酶抑制剂。
J Enzyme Inhib Med Chem. 2012 Oct;27(5):730-43. doi: 10.3109/14756366.2011.611136. Epub 2011 Oct 21.
10
3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.作为 WT 和 Y188L 突变 HIV-1 非核苷逆转录酶抑制剂的 3,4,5-三取代-1,2,4-4H-三唑:基于对接的 CoMFA 和 CoMSIA 分析。
J Mol Model. 2011 Jul;17(7):1537-50. doi: 10.1007/s00894-010-0857-7. Epub 2010 Oct 5.